欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0902/001
药品名称Tenofovir disoproxil Sandoz
活性成分
    • Tenofovir 245.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz A/S Edvard Thomsens Vej 14 2300 Copenhagen S
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Tenofovir Sandoz 245 mg – Filmtabletten
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Tenofovir disoproxil Sandoz
    • Estonia (EE)
      TENOFOVIR DISOPROXIL SANDOZ
    • Czechia (CZ)
      Tenofovir disoproxil Sandoz
    • Romania (RO)
    • Croatia (HR)
      Tenofovirdizoproksil Sandoz 245 mg filmom obložene tablete
许可日期2016/11/29
最近更新日期2025/02/14
药物ATC编码
    • J05AF07 tenofovir disoproxil
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase